Venous tromboembolism risk factors and prophylaxis

Chairpersons: O. Dahl (DK), P. Kyrle (AT)

Controversial issues regarding thromboprophylaxis in surgical patients

Ola Dahl (UK)

08:00 - 08:30

Prophylaxis in medical patients: how and for whom?

Patrick Mismetti (FR)

08:30 - 09:00

Obesity, metabolic syndrome and venous tromboembolism

Marie-Christine Alessi (FR)

09:00 - 09:30

Controversies in haemophilia treatment

Chairpersons: P. Lollar (US), C. Négrier (FR)

Gene transfer for inherited bleeding disorders

Katherine High (US)

08:00 - 08:30

Improved therapeutic agents for haemophilia

Pete Lollar (US)

08:30 - 09:00

Plasma-derived versus recombinant products
 for haemophilia treatment?
Jenny Goudemand (FR)

09:00 - 09:30

Methodological issues: study design and drug safety

Chairpersons: A. Leizorovicz (FR), B. L. Davidson (US)

Study design, level of evidence and guidelines

Alain Leizorovicz (FR)

Wendy Lim (CA)

09:00 - 09:30

The fibrinolytic system and cell surface proteolysis

Chairpersons: F. Blasi (IT), B. Binder (AT)

Annexin II and fibrinolysis

Francesco Blasi (IT)

New Roles for old coagulation factors

Chairpersons: K. T. Preissner (DE), M. M. Levi (NL)

Novel functions of protein S

Thomas Renné (DE)

Platelet-pathogen interactions

Chairpersons: E. Cramer-Bordé (FR), B. E. Kehrel (DE)

Platelets and bacteria

Endothelial precursor cells

Chairpersons: F. Dignat-George (FR), A. D. Blann (UK)

Haematopoietic stem cells localization in the embryonic vessel wall

Haemostasis and surgery

Chairpersons: C.M. Samama (FR),  W. Korte (CH)

Antithrombotic therapy and surgery

The Marion J. Barnhart Memorial Lecture

Chairpersons: D. Meyer (FR), K. J. Clemetson (CH)

From megakaryocytes to the platelet

The Kenneth M. Brinkhous Memorial Lecture (Endowed by Wyeth)

Chairpersons: G. C. White (US), P. de Moerloose (CH)

Von Willebrand disease type 1

Chairpersons: R. Verhaeghe (BE), D. Hayoz (CH)

Drug-eluting stents: trading thrombosis for restenosis?

Chairpersons: M. M. Samama (FR), A. S. Gallus (AU)

Chairpersons: H. Weiss (US), C. Balduini (IT)

Approach to the diagnosis and management of mild bleeding disorders

The Pia Glas - Greenwalt Memorial Lecture

Chairpersons: N. A. Booth (UK), W. Ruf (US)

Activated Protein C

Enrico Di Cera (US)

Chairpersons: J. E. Italiano (US), C. Ward (AU)

From stem cell to megakaryocyte

Chairpersons: V. van Hinsbergh (NL), C. Ruegg (CH)

Endothelial cell heterogeneity and thrombosis

Risk stratification and outcome in venous tromboembolism

Chairpersons: S. Z. Goldhaber (US), G. C. Agnelli (IT)

Long-term outcome after deep vein thrombosis

Susan Kahn (CA)

08:00 - 08:30

Risk stratification in acute pulmonary embolism: how and what for?

Samuel Z. Goldhaber (US)

08:30 - 09:00

Long-term prognosis of pulmonary embolism

Guy Meyer (FR)

09:00 - 09:30

Haemophilia inhibitors

Chairpersons: J. M. Saint-Rémy (BE), G. Dolan (UK)

Anti-idiotypic monoclonal antibodies for treatment of factor VIII inhibitors

Jean-Marie Saint-Rémy (BE)

08:00 - 08:30

Genetic and environmental risk factors for FVIII inhibitor development

Jan Astermark (SE)

08:30 - 09:00

Rare bleeding disorders

Chairpersons: A. Zivelin (IL), C. Lee (UK)

What do we expect from the International Registry?

Flora Peyvandi (IT)

08:00 - 08:30

Clinical phenotypes and factor VII genotype in
congenital factor VII deficiency

Jean-François Schved (FR)

08:30 - 09:00

Factor XI phenotype-genotype correlations
Ariella Zivelin (IL)

09:00 - 09:30

Fibrinolysis and the central nervous system

Chairpersons: D. Lawrence (US), D. Collen (BE)

Regulation of plasminogen activator activation in the central nervous system

Sidney Stricklandor (US)

Protein C

Chairpersons: B. Dahlbäck (SE), D. Lane (UK)

Protein C pathway

Charles Esmon (US)

Platelet signaling mechanisms

Chairpersons: S. Watson (UK), R. R. Montgomery (US)

Contact-dependent interactions that affect thrombus growth and stability

Models of arterial and venous thrombosis

Chairpersons: B. C. Furie (US), G. J. Johnson (US)

In vivo monitoring of thrombus formation

New cellular imaging approaches

Chairpersons: S. Jackson (AU), W. Ouwehand (UK)

Visual approach to proteomics

The Wright - Schulte Memorial Lecture

Chairpersons: C. Ruegg (CH), F. R. Rosendaal (NL)

Cell matrix adhesion in vascular development

A lecture endowed by The Désiré Collen Foundation

Chairpersons: J. M. Freyssinet (FR), C. Chesterman (AU)

Thrombus formation in vivo

Chairpersons: J. N. Fiessinger (FR), A. Perrier (CH)

Venous and arterial thrombosis: is there a link?

Chairpersons: A. K. Kakkar (UK), C. W. Francis (US)

Chairpersons: E. Berntorp (SE), R. d'Oiron (FR)

Immune tolerance for Factor VIII inhibitors in haemophilia A: current strategies and future directions

Chairpersons: M. Schapira (CH), J. Rosing (NL)

 Exosites in the specificity of blood coagulation reactions

Chairpersons: A. Nurden (FR), D.R. Phillips (US)

Programmed autologous cleavage of platelet receptors

Chairpersons: P. de Groot (NL), A. Greinacher (DE)

Vascular proteomics

Chairpersons: O. Matsuo (JP), D.C. Rijken (NL)

Structure of fibrin: impact on clot stability

Chairpersons: G. D. Lowe (UK), B. Imhof (CH)

Plaque progression and regression in atherothrombosis

Chairpersons: H. Bounameaux (CH), P. M. Mannucci (IT)

Integrated diagnostic strategy for venous thromboembolism

Philip S. Wells (CA)

Distal DVT: worth diagnosing? Yes

Sebastian Schellong (DE)

Distal DVT: worth diagnosing? No

Marc Righini (CH)

Chairpersons: H. Bounameaux (CH), F. Bachmann (CH)

FXa or thrombin: is Xa a better target?

Jack Ansell (US)

FXa or thrombin: is thrombin a better target?

Jeffrey Weitz (CA)

Thrombosis and bleeding disorders outside the Western countries

The Duckert - Koller - Lüscher Memorial Lecture

Chairpersons: M. H. Prins (NL), G. De Gaetano (IT)

Combined antiplatelet and anticoagulant therapy: clinical benefits, risks and costs

Chairpersons: J. Emmerich (FR), T. Brighton (AU)

Chairpersons: H. Salem (AU), J. F. Schved (FR)

Investigation and treatment of menorrhagia

Chairpersons: D. M. Monroe (US), P. M. Sandset (NO)

 The central role of thrombin in haemostasis

Chairpersons: M. Hoylaerts (BE), C. Mannhalter (AT)

Models to evaluate antiplatelet agents

Chairpersons: D. Fitzgerald (IE), U. Walter (DE)

Platelet genomics and the risk of atherothrombosis

Chairpersons: S. Lord (US), H. R. Lijnen (BE)

Congenital disorders of fibrinogen

Chairpersons: J. H. Mc Vey (UK), D. D. Wagner (US)

Zebrafish: from haematology to hydrology

Treatment of venous tromboembolism: controversies

Chairpersons: S. Schulman (CA), H. Décousus (FR)

Risk stratification of venous tromboembolism recurrence

Marc Rodger (CA)

08:00 - 08:30

Optimal duration of anticoagulant treatment in patients with venous tromboembolism

Giancarlo Agnelli (IT)

08:30 - 09:00

Treatment of antiphospholipid syndrome

Sam Schulman (CA)

09:00 - 09:30

Current and future assays of haemostasis

Chairpersons: M. Shima (JP), M. Greaves (UK)

Global assay using clot waveform and thrombin generation assays

Midori Shima (JP)

08:00 - 08:30

Monitoring haemostatic response using dynamic fibrin generation methods

Benny Sorensen (DK)

08:30 - 09:00

Global assays of platelet function in diagnostic testing
Catherine Hayward (CA)

09:00 - 09:30

Platelet disorders: clinical aspects

Chairpersons: A. Goodall (UK), M. Cattaneo (IT)

Clinical approach to heparin-induced thrombocytopenia

Thrombosis in children

Chairpersons: M. Manco-Johnson (US), P. Monagle (AU)

Central venous line related thrombosis in children

Fenella Kirkham (UK)

Anthony Chan (CA)

09:00 - 09:30

Thrombin

Chairpersons: J. A. Huntington (UK), A. Rezaie (US)

Non PAR receptors for thrombin

James A. Huntington (UK)

Thrombotic microangiopathies and ADAMTS 13

Chairpersons: D. Motto (US), Y. Fujimura (JP)

Clinical aspects of hereditary and acquired thrombotic thrombocytopenic purpura

Kenji Soejima (JP)

Microparticles

Chairpersons: N. Mackman (US), A. Sturk (NL)

Clinical significance of microparticles

The VWF-GPIb axis

Chairpersons: J. E. Sadler (US), J. Lopez (US)

The VWF-GPIb axis as a therapeutic target

The Sol Sherry Memorial Lecture

Chairpersons: K. A. Bauer (US), E. K. O. Kruithof (CH)

Fibrin and fibrinolysis in infection and host defence

The  Shirley Johnson Memorial Lecture

Chairpersons: B. Lämmle (CH), B. C. Furie (US)

VKORC1, the molecular target of coumarins

Chairpersons: B. Brenner (IL), J. Conard (FR)

Thrombophilia and pregnancy complications: causation or association?

Chairpersons: P. Gaussem (FR), J.H. Beer (CH)

Chairpersons: I. Peake (UK), U. Seligsohn (IL)

Phenotype heterogeneity of severe haemophilia

Frank C. Church (US)

Chairpersons: A. Gallino (CH), C. Weber (DE)

Platelets, inflammation and atherosclerosis

Chairpersons: D. K. Newman (US), J. W. Heemskerk (NL)

Platelet receptor crosstalk in collagen-induced activation of platelets

Chairpersons: I. Juhan-Vague (FR), D. Ginsburg (US)

Regulation of plasminogen activation

Chairpersons: R. De Caterina (IT), Y. Ikeda (JP)

Endothelial progenitor cells